5,0
12. Mai 2025
Ehemaliger Mitarbeiter, mehr als 10 Jahre
Wilmington, DE
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Good salaries, dynamic company, big enough to have multiple paths for advancement.
Kontras
Still a little staid because of its British heritage, but that’s not a bad thing. More of a sense of family because of this. Just be prepared - as therapeutic areas or approaches change, opportunities can dry up and new opportunities are often filled by outsiders - that’s just the nature of pharma.